Edaravone Improved Behavioral Abnormalities, Alleviated Oxidative Stress Inflammation, and Metabolic Homeostasis Pathways in Depression

Figure 7

The effect of Edaravone (EDV) treatment on (a) AMPK, (b) Tlr-4 and (c) BDNF expression level. Values are expressed as the mean ± SD and were analyzed using one-way ANOVA followed by Tukey’s post hoc test. Significant difference was accepted at (NS = not significant, #p <0.05, ##p <0.01, ###p <0.001) (n =3).

(a)

(b)

(c)